| 10/17/2024 3:54 PM | MorphoSys (1340243) Filer | Form 15-12G | |
| 10/04/2024 3:21 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:24 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:27 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:30 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:33 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:36 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:18 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:16 PM | MorphoSys (1340243) Filer | Form POSASR | |
| 08/27/2024 9:14 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/15/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC 13D/A | |
Get the Latest News and Ratings for MOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/13/2024 3:31 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 08/07/2024 3:51 PM | MorphoSys (1340243) Subject | Form SC 14D9/A | |
| 08/07/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 08/05/2024 7:14 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/02/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 08/01/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/31/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/30/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/29/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/25/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/25/2024 3:05 PM | MorphoSys (1340243) Filer | Form 25 Notification of the removal from listing and registration of matured, redeemed or retired securities | |
| 07/18/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/18/2024 10:25 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/12/2024 3:20 PM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/11/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/05/2024 5:48 AM | MorphoSys (1340243) Subject | Form SC 14D9 | |
| 07/05/2024 5:02 AM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T | |
| 07/02/2024 9:18 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/21/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC 13D/A | |
| 06/21/2024 9:07 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/20/2024 3:41 PM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/20/2024 3:33 PM | MorphoSys (1340243) Subject | Form SC14D9C | |
| 06/20/2024 2:38 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-C | |
| 06/17/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC 13D/A | |
| 06/10/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC 13D/A | |
| 06/10/2024 11:06 AM | GOLDMAN SACHS GROUP INC (886982) Filed by MorphoSys (1340243) Subject | Form SC 13G/A | |
| 06/10/2024 10:01 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/06/2024 3:36 PM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/05/2024 9:22 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/04/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
Whitney Tilson: “A New Kind of Civil War Begins in Less Than 100 Days” (Ad) President Trump says AI regulation will not stop what he calls the greatest economic engine in history, bigger than oil, gold, diamonds, or the internet. Meanwhile, The New Republic reports Republicans are eager to rein in AI ahead of the midterms.
Whitney Tilson, the analyst CNBC once called The Prophet for calling the dot-com crash, the Bear Stearns and Lehman collapses, and the 2009 market bottom, says a new divide begins in 100 days with major implications for portfolios.
Tilson lays out what he believes could separate winning and losing portfolios over the next six months. Watch Whitney Tilson's urgent briefing and prepare your portfolio now |
| 06/04/2024 9:17 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/31/2024 9:17 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/29/2024 9:17 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/28/2024 9:16 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/24/2024 9:13 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/23/2024 1:19 PM | MorphoSys (1340243) Subject | Form SC 14D9/A | |
| 05/23/2024 9:11 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/23/2024 8:04 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/21/2024 9:07 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/17/2024 9:15 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/16/2024 3:43 PM | MorphoSys (1340243) Subject | Form SC 14D9/A | |
| 05/16/2024 3:31 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 05/16/2024 9:11 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/15/2024 9:09 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/14/2024 9:27 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/13/2024 9:19 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/10/2024 9:31 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/08/2024 9:08 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/07/2024 3:45 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 05/07/2024 9:24 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/06/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 05/06/2024 9:07 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/03/2024 9:29 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/02/2024 3:31 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 05/02/2024 9:43 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/30/2024 9:07 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/30/2024 7:57 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/29/2024 3:15 PM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/29/2024 9:17 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/26/2024 9:11 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/25/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 04/25/2024 9:38 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/24/2024 10:03 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/23/2024 9:14 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/22/2024 9:32 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/19/2024 9:17 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/18/2024 3:31 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 04/18/2024 1:33 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC 13D | |
| 04/18/2024 9:13 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/17/2024 3:49 PM | MorphoSys (1340243) Subject | Form SC 14D9/A | |
| 04/17/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 04/16/2024 4:07 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 04/16/2024 9:12 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/15/2024 2:44 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 04/12/2024 9:54 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/11/2024 10:57 AM | MorphoSys (1340243) Subject | Form SC 14D9 | |
| 04/11/2024 5:01 AM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T | |
| 04/09/2024 9:07 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/08/2024 9:19 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/04/2024 9:15 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
The case for $20,000 gold before year end (Ad) President Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and America's $40 trillion national debt to a potential surge in gold prices, with some forecasts pointing to $10,000 or even $20,000 gold.
Dr. David Eifrig, a 40-year market veteran and former Goldman Sachs Vice President, says an unusual plan involving Trump and two other top officials could fuel the biggest gold bull run in decades.
Eifrig has shared his top gold pick tied to this developing story. Read the full gold report and see Eifrig's top pick now |
| 04/02/2024 9:08 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/27/2024 12:16 PM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/26/2024 10:15 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/25/2024 10:37 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/22/2024 10:17 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/22/2024 5:47 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/21/2024 10:27 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/20/2024 3:12 PM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/20/2024 10:13 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |